Risk of post-injection endophthalmitis peaks within the first three injections of anti-vascular endothelial growth factor therapy: A nationwide registry-based study.

Benjamin Sommer Thinggaard Frederik Nørregaard PedersenRyo KawasakiJimmi WiedYousif Subhi Jakob GrauslundLonny Stokholm

Published in: Acta ophthalmologica (2024)

Based on 16 years of nationwide registry data, this study identified a low and stable incidence of PIE. Notably, the highest risk of endophthalmitis was within the first three anti-VEGF injections.

Keyphrases

vascular endothelial growth factor
ultrasound guided
endothelial cells
platelet rich plasma
cross sectional
risk factors
electronic health record
cataract surgery
big data
stem cells
machine learning
mesenchymal stem cells
deep learning
artificial intelligence